_PRIVATE_LIMITED.webp)
Valgenesis (India) Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.26 Cr
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 98.45%
- Profit Growth 1092.03%
- Ebitda 377.85%
- Net Worth 91.18%
- Total Assets 114.73%
About Valgenesis (India)
Valgenesis (India) Private Limited (VIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 May 2006 and has a history of 18 years and nine months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.26 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishnakumar Ramachandran and M Sivakumar serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72200TN2006PTC059957
- Company No.
059957
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2006
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Valgenesis (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
M Sivakumar  | Director | 24-May-2006 | Current |
Krishnakumar Ramachandran  | Director | 20-Aug-2010 | Current |
Financial Performance of Valgenesis (India).
Valgenesis (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.45% increase. The company also saw a substantial improvement in profitability, with a 1092.03% increase in profit. The company's net worth Soared by an impressive increase of 91.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Valgenesis (India)?
In 2023, Valgenesis (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cologenesis Healthcare Private LimitedKrishnakumar Ramachandran and M Sivakumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Valgenesis (India)?
Valgenesis (India) has a workforce of 437 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Valgenesis (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Valgenesis (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
